Search Results - "Cesario, L."

Refine Results
  1. 1

    Clinical prognostic factors in canine histiocytic sarcoma by Dervisis, N. G., Kiupel, M., Qin, Q., Cesario, L.

    Published in Veterinary & comparative oncology (01-12-2017)
    “…Canine histiocytic sarcoma (HS) is an aggressive neoplasia with variable clinical course and fatal outcome. The goals of this study were to evaluate a large…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study by Funch, Katarina M., Thysen, Sanne M., Rodrigues, Amabelia, Martins, Cesario L., Aaby, Peter, Benn, Christine S., Fisker, Ane B.

    Published in Human vaccines & immunotherapeutics (03-10-2018)
    “…Background: Bacillus Calmette-Guérin (BCG) vaccination may have beneficial non-specific effects on child survival, the effects being stronger for children…”
    Get full text
    Journal Article
  5. 5

    Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau by Fisker, Ane B, Biering-Sørensen, Sofie, Lund, Najaaraq, Djana, Queba, Rodrigues, Amabelia, Martins, Cesario L, Benn, Christine S

    Published in Vaccine (31-08-2016)
    “…Highlights • Vaccines have sex-differential non-specific effects affecting mortality. • The transition from DTP to measles vaccine lowers female/male mortality…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial by Benn, Christine S, Diness, Birgitte R, Balde, Ibraima, Rodrigues, Amabelia, Lausch, Karen R, Martins, Cesario L, Fisker, Ane B, Aaby, Peter

    Published in The Journal of nutrition (01-09-2014)
    “…Whether neonatal vitamin A supplementation (NVAS) should be policy in areas with vitamin A deficiency is debated. We observed that a smaller dose of vitamin A…”
    Get more information
    Journal Article
  8. 8

    Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau by Fisker, Ane B, Martins, Justiniano S D, Nanque, Line M, Jensen, Andreas M, Ca, Elsi J C, Nielsen, Sebastian, Martins, Cesario L, Rodrigues, Amabelia

    Published in Open forum infectious diseases (01-09-2022)
    “…Abstract Background Oral polio vaccine (OPV) may improve resistance to non-polio-infections. We tested whether OPV reduced the risk of illness and mortality…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Interaction between neonatal vitamin A supplementation and timing of measles vaccination: A retrospective analysis of three randomized trials from Guinea-Bissau by Benn, Christine S, Martins, Cesario L, Fisker, Ane B, Diness, Birgitte R, Garly, May-Lill, Balde, Ibraima, Rodrigues, Amabelia, Whittle, Hilton, Aaby, Peter

    Published in Vaccine (22-09-2014)
    “…Highlights • Early measles vaccine and neonatal vitamin A supplementation may become policy in low-income countries. • Vaccines and vitamin A may interact. •…”
    Get full text
    Journal Article
  11. 11

    Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age by Brønd, Marie, Martins, Cesario L, Byberg, Stine, Benn, Christine S, Whittle, Hilton, Garly, May-Lill, Aaby, Peter, Fisker, Ane B

    “…Two doses of measles vaccine (MV) might reduce the nonmeasles mortality rate more than 1 dose of MV does. The effect of 2 versus 1 dose on morbidity has not…”
    Get full text
    Journal Article
  12. 12

    Sword of Damocles cutting through the life stages of women with ovarian cancer by Cesario, Sandra K, Nelson, Leslie S, Broxson, Anita, Cesario, Anastasia L

    Published in Oncology nursing forum (01-09-2010)
    “…To identify the most prevalent worries and fears of women diagnosed with ovarian cancer. Online survey design was used to elicit qualitative data. Examination…”
    Get full text
    Journal Article
  13. 13

    Diagnosis and ultrasonographic appearance of hepatic metastasis in six cases of canine appendicular osteosarcoma (2005–2013) by Cesario, L, Garrett, LD, Barger, AM, O'Brien, RT, Fan, TM

    Published in Australian veterinary journal (01-05-2016)
    “…OBJECTIVES: The aims of this retrospective study were to identify clinical cases of dogs with appendicular osteosarcoma (OSA) in which hepatic metastasis was…”
    Get full text
    Journal Article
  14. 14

    Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival by Aaby, Peter, Martins, Cesário L., Garly, May-Lill, Andersen, Andreas, Fisker, Ane B., Claesson, Mogens H., Ravn, Henrik, Rodrigues, Amabelia, Whittle, Hilton C., Benn, Christine S.

    Published in Clinical infectious diseases (15-08-2014)
    “…Background. Measles vaccine (MV) has a greater effect on child survival when administered in early infancy, when maternal antibody may still be present…”
    Get full text
    Journal Article
  15. 15

    Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial by Aaby, Peter, Martins, Cesário L, Garly, May-Lill, Balé, Carlito, Andersen, Andreas, Rodrigues, Amabelia, Ravn, Henrik, Lisse, Ida M, Benn, Christine S, Whittle, Hilton C

    Published in BMJ (30-11-2010)
    “…Objective To examine in a randomised trial whether a 25% difference in mortality exists between 4.5 months and 3 years of age for children given two standard…”
    Get full text
    Journal Article
  16. 16

    Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine by Aaby, Peter, Andersen, Andreas, Martins, Cesário L, Fisker, Ane B, Rodrigues, Amabelia, Whittle, Hilton C, Benn, Christine S

    Published in BMJ open (23-12-2016)
    “…BackgroundBCG and measles vaccine (MV) may have beneficial non-specific effects (NSEs). If an unplanned intervention with a vaccine (a natural experiment)…”
    Get full text
    Journal Article
  17. 17

    The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy by Aaby, Peter, Martins, Cesário L, Garly, May-Lill, Rodrigues, Amabelia, Benn, Christine S, Whittle, Hilton

    Published in BMJ open (01-01-2012)
    “…ObjectiveThe current policy of measles vaccination at 9 months of age was decided in the mid-1970s. The policy was not tested for impact on child survival but…”
    Get full text
    Journal Article
  18. 18

    Is early measles vaccination better than later measles vaccination? by Aaby, Peter, Martins, Cesário L, Ravn, Henrik, Rodrigues, Amabelia, Whittle, Hilton C, Benn, Christine S

    “…WHO recommends delaying measles vaccination (MV) until maternal antibody has waned. However, early MV may improve child survival by reducing mortality from…”
    Get full text
    Journal Article
  19. 19

    Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival by Benn, Christine S, Martins, Cesário L, Andersen, Andreas, Fisker, Ane B, Whittle, Hilton C, Aaby, Peter

    Published in Frontiers in pediatrics (07-02-2020)
    “…In trials of early two-dose measles vaccination (MV), with the first dose being given before 9 months of age, vaccination in the presence of maternal antibody…”
    Get full text
    Journal Article
  20. 20

    Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial by Martins, Cesário L, Garly, May-Lill, Balé, Carlito, Rodrigues, Amabelia, Ravn, Henrik, Whittle, Hilton C, Lisse, Ida M, Aaby, Peter

    Published in BMJ (09-08-2008)
    “…Objective To examine the protective efficacy of measles vaccination in infants in a low income country before 9 months of age.Design Randomised clinical…”
    Get full text
    Journal Article